Investigation of Adults With Congenital Heart Disease in the Scope of the ICF

Last updated: March 7, 2023
Sponsor: Hacettepe University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pentalogy Of Cantrell

Congenital Heart Disease

Heart Disease

Treatment

N/A

Clinical Study ID

NCT05774158
03032023
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Congenital heart disease (CHD) is one of the common birth defects with a prevalence of approximately 1 in 1000 live births worldwide. While 15% of patients with CHD reached adulthood in the past, this rate is close to 90% today thanks to advancing medicine and technology.As individuals with CHD age, they may be affected by acquired cardiovascular risk factors common in the general population in addition to heart diseases such as arterial hypertension, obesity, and diabetes, increasing the risk of metabolic disease, stroke, and coronary artery disease. In addition to these risk factors, the disease affects both the social and familial environment of the patients. In addition to the mortality and morbidity of patients, which was the most important outcome measure in the past, quality of life has become the subject of current research. The International Classification of Functioning and Health (ICF) was adopted in 2001 for the use of a common, standard language and framework for describing health and health-related conditions, and is an international and standardized classification system that can evaluate functioning, disability and health holistically. There are no studies in the literature evaluating body structure, function and activity and participation in adults with congenital heart disease within the scope of ICF. Therefore, the aim of this study is; It is the evaluation of adults with CHD according to ICF sub-parameters (body structure and functions, activity and participation, and environmental factors) and the correlation of ICF parameters with other evaluation methods.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with congenital heart disease
  • Being between the ages of 18-65
  • To have been informed about the study and given written consent to participate in thestudy.

Exclusion

Exclusion Criteria:

  • Having a neurological, orthopedic or any systemic disease,
  • Presence of infection and malignancy,
  • Cognitive, psychological and mental status are not suitable for evaluations,
  • To undergo another surgery other than cardiac surgery.

Study Design

Total Participants: 30
Study Start date:
December 01, 2022
Estimated Completion Date:
December 01, 2023

Connect with a study center

  • Hacettepe University

    Ankara,
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.